Center for Sickle Cell Disease, Department of Medicine, Howard University College of Medicine, Washington, DC, United States.
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Oct 1;906:25-32. doi: 10.1016/j.jchromb.2012.08.011. Epub 2012 Aug 15.
In the current study, we developed a HPLC method to quantitatively measure the permeability of the BpT-based chelators, 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT) and 2-benzoylpyridine 4-allyl-3-thiosemicarbazone (Bp4aT), across human colorectal adenocarcinoma (Caco-2) monolayers as a model of gut absorption. In aqueous solution, Bp4eT and Bp4aT formed inter-convertible Z and E isomers that were resolved by HPLC. Peak area was linear with respect to chelator concentration. Acceptable within-day and between-day precision (<22%) and accuracy (85-115% of true values) were obtained over a range of 1.0-100μM for Bp4eT and 1.5-300μM for Bp4aT. Limits of detection were 0.3μM and 1μM for Bp4eT and Bp4aT, respectively, while corresponding limits of quantification were 1μM and 5μM. Both chelators showed significant ability to chelate iron in THP-1 cells using a calcein-based assay and no apparent cytotoxicity was observed within 24h. Ratios of the apical to basolateral and basolateral to apical transport for Bp4eT were 1.10 and 0.89 at 100μM and 300μM respectively, indicating equal bi-directional movement of the compounds. Similarly, ratios were 0.77 and 0.92 for Bp4aT, respectively. This study demonstrates that Bp4eT and Bp4aT can be efficiently transported through Caco-2 cells and can potentially be formulated for oral delivery.
在本研究中,我们开发了一种 HPLC 方法来定量测量基于 BpT 的螯合剂 2-苯甲酰基吡啶 4-乙基-3-硫代缩氨基脲(Bp4eT)和 2-苯甲酰基吡啶 4-烯丙基-3-硫代缩氨基脲(Bp4aT)在人结直肠腺癌细胞(Caco-2)单层作为肠道吸收模型中的渗透性。在水溶液中,Bp4eT 和 Bp4aT 形成可相互转化的 Z 和 E 异构体,可通过 HPLC 分离。峰面积与螯合剂浓度呈线性关系。在 1.0-100μM 范围内,Bp4eT 的日内和日间精密度(<22%)和准确度(真实值的 85-115%)均可接受,Bp4aT 的日内和日间精密度(<22%)和准确度(真实值的 85-115%)均可接受,Bp4aT 的日内和日间精密度(<22%)和准确度(真实值的 85-115%)均可接受,Bp4aT 的范围为 1.5-300μM。Bp4eT 和 Bp4aT 的检测限分别为 0.3μM 和 1μM,定量限分别为 1μM 和 5μM。两种螯合剂在使用钙黄绿素测定法测定 THP-1 细胞中铁的螯合能力方面均表现出显著的能力,并且在 24 小时内未观察到明显的细胞毒性。在 100μM 和 300μM 时,Bp4eT 的顶端至基底侧和基底侧至顶端转运的比率分别为 1.10 和 0.89,表明化合物的双向运动相等。同样,Bp4aT 的比率分别为 0.77 和 0.92。本研究表明,Bp4eT 和 Bp4aT 可有效穿过 Caco-2 细胞转运,并且可能可被制成口服剂型。